Prognostic Factors in Advanced Hodgkin's Disease
Author Information
Author(s): SM Lee, JA Radford, WDJ Ryder, CD Collins, DP Deakin, D Crowther
Primary Institution: Christie Hospital NHS Trust
Hypothesis
Can a very high-risk group of patients with advanced Hodgkin's disease be identified based on presenting characteristics?
Conclusion
No sufficiently high-risk group of patients with Hodgkin's disease was identified for whom high-dose chemotherapy could be recommended as part of primary treatment.
Supporting Evidence
- The study analyzed 453 patients who did not progress in the first 6 months after starting chemotherapy.
- The worst prognostic group had a freedom from progression rate of 57% at 5 years.
- Four other prognostic indices were evaluated but none were successful in identifying a very high-risk group.
Takeaway
The study looked at patients with advanced Hodgkin's disease to see if some were at high risk of getting worse, but it found that most patients do well with standard treatment.
Methodology
Data from 453 patients aged under 60 years with advanced Hodgkin's disease were analyzed using Cox regression to evaluate prognostic factors.
Limitations
The study could not identify a high-risk group for high-dose chemotherapy, and some data were missing for key prognostic variables.
Participant Demographics
Patients were aged under 60 years and included both males and females.
Want to read the original?
Access the complete publication on the publisher's website